Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate FDA Budget Bill Mandates $1 Mil. For Reprocessing Oversight

This article was originally published in The Gray Sheet

Executive Summary

A Democratic amendment contained in the Senate agriculture appropriations bill (S 1233) for fiscal year 2000 directs FDA's Center for Devices and Radiological Health to allocate $1 mil. of its budget for overseeing the practice of medical device reprocessing. The legislation cleared the chamber by voice vote on Aug. 4.

You may also be interested in...



Earmarked Funds For Premarket Review Supported By Device Associations

Senate and House conferees should retain the $7 mil. and 45 FTEs earmarked by the Senate version of the FY 2000 agriculture appropriations bill (S 1233) for medical device reviews, the Health Industry Manufacturers Association urges in a Sept. 13 letter to the Senate Appropriations Committee.

Earmarked Funds For Premarket Review Supported By Device Associations

Senate and House conferees should retain the $7 mil. and 45 FTEs earmarked by the Senate version of the FY 2000 agriculture appropriations bill (S 1233) for medical device reviews, the Health Industry Manufacturers Association urges in a Sept. 13 letter to the Senate Appropriations Committee.

States Taking Legislative Initiative On Single-Use Medical Device Reuse

An interim hearing before the California State Assembly Health Committee on legislation banning the reuse of single-use medical devices is expected before year-end.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel